Diffuse large B-cell lymphoma of the breast: prognostic factors and treatment outcomes

about

Myeloid cells as orchestrators of the tumor microenvironment: novel targets for nanoparticular cancer therapy.Role of core needle biopsy in primary breast lymphoma.Primary extra-nodal diffuse large B-cell lymphoma: A prognostic analysis of 141 patients.

P2860

Q38961842-5140E1DE-E821-43F9-BC16-8DC4DB2C55AC Q47371578-2459018D-DD4A-4C1A-BCC8-E86C7D83D6E0 Q55712161-0C7F89C0-427D-4B50-91A6-B76A7421BA09

P2860

Diffuse large B-cell lymphoma of the breast: prognostic factors and treatment outcomes

Item

http://www.wikidata.org/entity/Q36787879

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Diffuse large B-cell lymphoma of the breast: prognostic factors and treatment outcomes

@en

type

Item

label

Diffuse large B-cell lymphoma of the breast: prognostic factors and treatment outcomes

@en

prefLabel

Diffuse large B-cell lymphoma of the breast: prognostic factors and treatment outcomes

@en

P1476

Diffuse large B-cell lymphoma of the breast: prognostic factors and treatment outcomes

@en

P2093

Dong Qian

http://www.w3.org/2001/XMLSchema#string

Jin-Qiang You

http://www.w3.org/2001/XMLSchema#string

Li-Ming Xu

http://www.w3.org/2001/XMLSchema#string

Monika Joks

http://www.w3.org/2001/XMLSchema#string

Xiu-Li Chen

http://www.w3.org/2001/XMLSchema#string

Yao Sun

http://www.w3.org/2001/XMLSchema#string

Zhi-Yong Yuan

http://www.w3.org/2001/XMLSchema#string

P2860

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

Stromal gene signatures in large-B-cell lymphomas

Primary and secondary breast lymphoma: prevalence, clinical signs and radiological features

Primary bilateral adrenal lymphoma.

Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study

Primary breast lymphomas.

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.

Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes.

P304

2069-2080

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S98566

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27103833

http://www.w3.org/2001/XMLSchema#string

P932

4827925

http://www.w3.org/2001/XMLSchema#string

Diffuse large B-cell lymphoma of the breast: prognostic factors and treatment outcomes

about

P2860

P2860

Diffuse large B-cell lymphoma of the breast: prognostic factors and treatment outcomes

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932